Evaluation of 4-Factor PCC in DOAC-associated Intracranial Hemorrhage

Description

Intracranial hemorrhage (ICH) can occur due to traumatic and spontaneous events.1 The incidence of non-traumatic, spontaneous ICH is approximately 40,000 to 67,000 cases per year while the incidence of traumatic brain injury (TBI) is nearly 1.7 million annually

Conditions

Intracranial Hemorrhage

Talk to us

Study Overview

On this page

Study Details

Study overview

Intracranial hemorrhage (ICH) can occur due to traumatic and spontaneous events.1 The incidence of non-traumatic, spontaneous ICH is approximately 40,000 to 67,000 cases per year while the incidence of traumatic brain injury (TBI) is nearly 1.7 million annually

Evaluation of 4-Factor PCC in DOAC-associated Intracranial Hemorrhage

Evaluation of 4-Factor PCC in DOAC-associated Intracranial Hemorrhage

Condition
Intracranial Hemorrhage
Intervention / Treatment

-

Contacts and Locations

Dallas

Methodist Dallas Medical Center, Dallas, Texas, United States, 75203

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * • ≥18 years of age
  • * ICH (traumatic and spontaneous)
  • * Administration of at least one dose of 4F-PCC
  • * Admitted to the MHS between July 1, 2018 and May 30, 2023
  • * Rivaroxaban or apixaban use prior to admission
  • * • Warfarin or dabigatran use prior to admission
  • * Prisoners
  • * Pregnancy
  • * \<18 years of age

Ages Eligible for Study

18 Years to 75 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Methodist Health System,

Tamara Reiter, PharmD, PRINCIPAL_INVESTIGATOR, Methodist Midlothian Medical Center

Study Record Dates

2024-07-13